Figari IS - Search Results

1

Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.

Kramer SM, Aggarwal BB, Eessalu TE, McCabe SM, Ferraiolo BL, Figari IS, Palladino MA Jr. Kramer SM, et al. Among authors: figari is. Cancer Res. 1988 Feb 15;48(4):920-5. Cancer Res. 1988. PMID: 2827889

2

Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.

Chang HL, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R. Chang HL, et al. Cancer Res. 1993 Sep 15;53(18):4391-8. Cancer Res. 1993. PMID: 8364935

3

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH. Ashkenazi A, et al. Among authors: figari is. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10535-9. doi: 10.1073/pnas.88.23.10535. Proc Natl Acad Sci U S A. 1991. PMID: 1660140 Free PMC article.

4

The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV. Tartaglia LA, et al. Among authors: figari is. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9292-6. doi: 10.1073/pnas.88.20.9292. Proc Natl Acad Sci U S A. 1991. PMID: 1718003 Free PMC article.

5

Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Figari IS, Mori NA, Palladino MA Jr. Figari IS, et al. Blood. 1987 Oct;70(4):979-84. Blood. 1987. PMID: 2820532 Free article.

6

In vivo anti-tumour activity of recombinant human tumour necrosis factor-alpha against Meth-A sarcoma requires L3T4-positive T cells.

Palladino MA, Figari IS. Palladino MA, et al. Among authors: figari is. Ann Inst Pasteur Immunol. 1988 May-Jun;139(3):299-301. doi: 10.1016/0769-2625(88)90144-4. Ann Inst Pasteur Immunol. 1988. PMID: 2901845 No abstract available.

7

The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.

Shalaby MR, Espevik T, Rice GC, Ammann AJ, Figari IS, Ranges GE, Palladino MA Jr. Shalaby MR, et al. Among authors: figari is. J Immunol. 1988 Jul 15;141(2):499-503. J Immunol. 1988. PMID: 2968403

8

Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.

Espevik T, Figari IS, Ranges GE, Palladino MA Jr. Espevik T, et al. Among authors: figari is. J Immunol. 1988 Apr 1;140(7):2312-6. J Immunol. 1988. PMID: 3280680

9

Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.

Palladino MA Jr, Patton JS, Figari IS, Shalaby MR. Palladino MA Jr, et al. Among authors: figari is. Ciba Found Symp. 1987;131:21-38. doi: 10.1002/9780470513521.ch3. Ciba Found Symp. 1987. PMID: 3330012 Review.

10

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

Ranges GE, Figari IS, Espevik T, Palladino MA Jr. Ranges GE, et al. Among authors: figari is. J Exp Med. 1987 Oct 1;166(4):991-8. doi: 10.1084/jem.166.4.991. J Exp Med. 1987. PMID: 3498791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters